Abilify®
Back to Test Catalogue
Aripiprazole, Serum/Plasma
Test ID: ARIP
Test
Aliases/Synonyms
Method
Chromatography/Mass Spectrometry
Report Includes
Aripiprazole
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Clinical Utility
Aripiprazole (Abilify®) is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. The analysis of aripiprazole is used to monitor compliance with drug therapy.
Test Location
Quest Diagnostics, California USA
Test Version
19-Jan-2023
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Collection Containers
Preferred
Red top (no additive)
Acceptable
Lavender top (EDTA)
Sample Volume
3 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 30 days |
Rejection Criteria
| Specimen | Gel-separator tube |
|---|
Test Version
19-Jan-2023
Performance / Interpretation
Method
Chromatography/Mass Spectrometry
Turnaround Time
9 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Aripirazole | ng/mL |
|
||
|
Steady state plasma levels in adults following a daily regimen have been reported as:
|
||||
Test Location
Quest Diagnostics, California USA
Test Version
19-Jan-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| ARIP | 63006 ARIPIPRAZOLE, QN, SERUM/PLASMA | ng/mL |
Test Version
19-Jan-2023